Global Drug-Gene Interaction Panel Market Growth (Status and Outlook) 2025-2031

Product Code: 1789962

Industry: Medical Care

Published: Nov 25,2025

Pages: 100

Delivery Time: 2-3 business days

Global Drug-Gene Interaction Panel Market Growth (Status and Outlook) 2025-2031

Product Code: 1789962

Industry: Medical Care

Published: Nov 25,2025

Pages: 100

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Drug-Gene Interaction Panel market size is predicted to grow from US$ 2838 million in 2025 to US$ 5090 million in 2031; it is expected to grow at a CAGR of 10.2% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

A Drug-Gene Interaction Panel is an integrated multigene testing platform designed to evaluate how individual genetic variations influence drug absorption, metabolism, transport, and pharmacodynamic response. The panel typically includes multiple loci associated with drug-metabolizing enzymes, transporters, pharmacological targets, and key metabolic pathways—such as CYP450 variants—to provide a comprehensive assessment in a single test. Its central value lies in enabling tailored drug selection, dosage optimization, and the prevention of adverse drug reactions, thereby enhancing treatment safety, efficacy, and predictability. With the rapid advancement of precision medicine, updated pharmacogenomics guidelines, and the growing use of clinical decision-support systems, Drug-Gene Interaction Panels are becoming essential tools for hospitals, pharmaceutical R&D, and translational research.The average gross   profit margin of this product is 55%.

The market for Drug-Gene Interaction Panels is expanding rapidly, driven by the maturation of precision medicine, the rising demand for adverse drug reaction management, and the clinical need for personalized pharmacotherapy. Regulatory agencies and professional organizations are updating PGx guidelines, introducing more gene-informed medications and positioning these panels as essential tools in hospital pharmacy and therapeutic decision-making. Additionally, pharmaceutical companies increasingly incorporate drug–gene interaction studies into drug development, boosting the panel’s use in clinical trials and real-world evidence research.

Despite strong momentum, the market faces challenges such as lack of unified technical standards, inconsistent interpretation of genotypes, and variable clinical adoption. In many countries, limited reimbursement policies slow market penetration. Differences in sample quality, interpretation expertise, and decision-support systems create risks related to result consistency. Moreover, stricter data privacy regulations place greater constraints on data transfer and inter-institution sharing.

Demand is shifting from single-gene assays toward multiplex panels that better support multidrug regimens and complex disease management. Oncology, neuropsychiatry, and cardiovascular therapy represent the fastest-growing application areas. Hospitals are adopting automated reporting and EMR-integrated PGx systems to enhance operational efficiency. Pharmaceutical companies increasingly rely on these panels for stratified clinical trials, subject selection, and mechanism-of-action studies, creating deeper structural demand.

Upstream components—such as capture probes, oligonucleotide primers, high-purity nucleases, fluorescent or enzyme-labeled probes, microfluidic chip substrates, and NGS reagents—form the technological backbone of these panels. Probe chemistry determines assay sensitivity and specificity; chip and microfluidic platforms influence throughput and automation; and reagent stability directly affects result reproducibility. Advancements in high-throughput sequencing and microfabrication continue to lower costs and improve clinical accessibility.

LPI (LP Information)' newest research report, the “Drug-Gene Interaction Panel Industry Forecast” looks at past sales and reviews total world Drug-Gene Interaction Panel sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug-Gene Interaction Panel sales for 2025 through 2031. With Drug-Gene Interaction Panel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Gene Interaction Panel industry.

This Insight Report provides a comprehensive analysis of the global Drug-Gene Interaction Panel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug-Gene Interaction Panel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug-Gene Interaction Panel market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Gene Interaction Panel and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Gene Interaction Panel.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Gene Interaction Panel market by product type, application, key players and key regions and countries.

Segmentation by Type:
    single-gene PGx Tests
    Targeted Multi-gene PGx Panels
    Comprehensive PGx Panels
    WGS-based Pharmacogenomics

Segmentation by Clinical Application Field:
    Pharmacogenomics Panel
    Oncology Drug-Gene Interaction Panel
    Others

Segmentation by Product Type:
    Predefined Panels
    Customized Panels

Segmentation by Application:
    Hospitals
    Cancer Research Institutes
    Reference Laboratories
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Invitae Corporation
    Neuberg Center for Genomic Medicine (NCGM)
    Sonic Healthcare
    10x Genomics
    Integrated DNA Technologies
    Celemics
    Agena Bioscience

List Of Tables

List of Tables
 Table 1. Drug-Gene Interaction Panel Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
 Table 2. Drug-Gene Interaction Panel Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of single-gene PGx Tests
 Table 4. Major Players of Targeted Multi-gene PGx Panels
 Table 5. Major Players of Comprehensive PGx Panels
 Table 6. Major Players of WGS-based Pharmacogenomics
 Table 7. Drug-Gene Interaction Panel Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 8. Global Drug-Gene Interaction Panel Market Size by Type (2020-2025) & ($ millions)
 Table 9. Global Drug-Gene Interaction Panel Market Size Market Share by Type (2020-2025)
 Table 10. Major Players of Pharmacogenomics Panel
 Table 11. Major Players of Oncology Drug-Gene Interaction Panel
 Table 12. Major Players of Others
 Table 13. Drug-Gene Interaction Panel Market Size CAGR by Clinical Application Field (2020 VS 2024 VS 2031) & ($ millions)
 Table 14. Global Drug-Gene Interaction Panel Market Size by Clinical Application Field (2020-2025) & ($ millions)
 Table 15. Global Drug-Gene Interaction Panel Market Size Market Share by Clinical Application Field (2020-2025)
 Table 16. Major Players of Predefined Panels
 Table 17. Major Players of Customized Panels
 Table 18. Drug-Gene Interaction Panel Market Size CAGR by Product Type (2020 VS 2024 VS 2031) & ($ millions)
 Table 19. Global Drug-Gene Interaction Panel Market Size by Product Type (2020-2025) & ($ millions)
 Table 20. Global Drug-Gene Interaction Panel Market Size Market Share by Product Type (2020-2025)
 Table 21. Drug-Gene Interaction Panel Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
 Table 22. Global Drug-Gene Interaction Panel Market Size by Application (2020-2025) & ($ millions)
 Table 23. Global Drug-Gene Interaction Panel Market Size Market Share by Application (2020-2025)
 Table 24. Global Drug-Gene Interaction Panel Revenue by Player (2020-2025) & ($ millions)
 Table 25. Global Drug-Gene Interaction Panel Revenue Market Share by Player (2020-2025)
 Table 26. Drug-Gene Interaction Panel Key Players Head office and Products Offered
 Table 27. Drug-Gene Interaction Panel Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 28. New Products and Potential Entrants
 Table 29. Mergers & Acquisitions, Expansion
 Table 30. Global Drug-Gene Interaction Panel Market Size by Region (2020-2025) & ($ millions)
 Table 31. Global Drug-Gene Interaction Panel Market Size Market Share by Region (2020-2025)
 Table 32. Global Drug-Gene Interaction Panel Revenue by Country/Region (2020-2025) & ($ millions)
 Table 33. Global Drug-Gene Interaction Panel Revenue Market Share by Country/Region (2020-2025)
 Table 34. Americas Drug-Gene Interaction Panel Market Size by Country (2020-2025) & ($ millions)
 Table 35. Americas Drug-Gene Interaction Panel Market Size Market Share by Country (2020-2025)
 Table 36. Americas Drug-Gene Interaction Panel Market Size by Type (2020-2025) & ($ millions)
 Table 37. Americas Drug-Gene Interaction Panel Market Size Market Share by Type (2020-2025)
 Table 38. Americas Drug-Gene Interaction Panel Market Size by Application (2020-2025) & ($ millions)
 Table 39. Americas Drug-Gene Interaction Panel Market Size Market Share by Application (2020-2025)
 Table 40. APAC Drug-Gene Interaction Panel Market Size by Region (2020-2025) & ($ millions)
 Table 41. APAC Drug-Gene Interaction Panel Market Size Market Share by Region (2020-2025)
 Table 42. APAC Drug-Gene Interaction Panel Market Size by Type (2020-2025) & ($ millions)
 Table 43. APAC Drug-Gene Interaction Panel Market Size by Application (2020-2025) & ($ millions)
 Table 44. Europe Drug-Gene Interaction Panel Market Size by Country (2020-2025) & ($ millions)
 Table 45. Europe Drug-Gene Interaction Panel Market Size Market Share by Country (2020-2025)
 Table 46. Europe Drug-Gene Interaction Panel Market Size by Type (2020-2025) & ($ millions)
 Table 47. Europe Drug-Gene Interaction Panel Market Size by Application (2020-2025) & ($ millions)
 Table 48. Middle East & Africa Drug-Gene Interaction Panel Market Size by Region (2020-2025) & ($ millions)
 Table 49. Middle East & Africa Drug-Gene Interaction Panel Market Size by Type (2020-2025) & ($ millions)
 Table 50. Middle East & Africa Drug-Gene Interaction Panel Market Size by Application (2020-2025) & ($ millions)
 Table 51. Key Market Drivers & Growth Opportunities of Drug-Gene Interaction Panel
 Table 52. Key Market Challenges & Risks of Drug-Gene Interaction Panel
 Table 53. Key Industry Trends of Drug-Gene Interaction Panel
 Table 54. Global Drug-Gene Interaction Panel Market Size Forecast by Region (2026-2031) & ($ millions)
 Table 55. Global Drug-Gene Interaction Panel Market Size Market Share Forecast by Region (2026-2031)
 Table 56. Global Drug-Gene Interaction Panel Market Size Forecast by Type (2026-2031) & ($ millions)
 Table 57. Global Drug-Gene Interaction Panel Market Size Forecast by Application (2026-2031) & ($ millions)
 Table 58. Invitae Corporation Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 59. Invitae Corporation Drug-Gene Interaction Panel Product Offered
 Table 60. Invitae Corporation Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 61. Invitae Corporation Main Business
 Table 62. Invitae Corporation Latest Developments
 Table 63. Neuberg Center for Genomic Medicine (NCGM) Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 64. Neuberg Center for Genomic Medicine (NCGM) Drug-Gene Interaction Panel Product Offered
 Table 65. Neuberg Center for Genomic Medicine (NCGM) Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 66. Neuberg Center for Genomic Medicine (NCGM) Main Business
 Table 67. Neuberg Center for Genomic Medicine (NCGM) Latest Developments
 Table 68. Sonic Healthcare Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 69. Sonic Healthcare Drug-Gene Interaction Panel Product Offered
 Table 70. Sonic Healthcare Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 71. Sonic Healthcare Main Business
 Table 72. Sonic Healthcare Latest Developments
 Table 73. 10x Genomics Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 74. 10x Genomics Drug-Gene Interaction Panel Product Offered
 Table 75. 10x Genomics Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 76. 10x Genomics Main Business
 Table 77. 10x Genomics Latest Developments
 Table 78. Integrated DNA Technologies Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 79. Integrated DNA Technologies Drug-Gene Interaction Panel Product Offered
 Table 80. Integrated DNA Technologies Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 81. Integrated DNA Technologies Main Business
 Table 82. Integrated DNA Technologies Latest Developments
 Table 83. Celemics Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 84. Celemics Drug-Gene Interaction Panel Product Offered
 Table 85. Celemics Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 86. Celemics Main Business
 Table 87. Celemics Latest Developments
 Table 88. Agena Bioscience Details, Company Type, Drug-Gene Interaction Panel Area Served and Its Competitors
 Table 89. Agena Bioscience Drug-Gene Interaction Panel Product Offered
 Table 90. Agena Bioscience Drug-Gene Interaction Panel Revenue ($ million), Gross Margin and Market Share (2020-2025)
 Table 91. Agena Bioscience Main Business
 Table 92. Agena Bioscience Latest Developments


List of Figures
 Figure 1. Drug-Gene Interaction Panel Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Drug-Gene Interaction Panel Market Size Growth Rate (2020-2031) ($ millions)
 Figure 6. Drug-Gene Interaction Panel Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 7. Drug-Gene Interaction Panel Sales Market Share by Country/Region (2024)
 Figure 8. Drug-Gene Interaction Panel Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 9. Global Drug-Gene Interaction Panel Market Size Market Share by Type in 2024
 Figure 10. Global Drug-Gene Interaction Panel Market Size Market Share by Clinical Application Field in 2024
 Figure 11. Global Drug-Gene Interaction Panel Market Size Market Share by Product Type in 2024
 Figure 12. Drug-Gene Interaction Panel in Hospitals
 Figure 13. Global Drug-Gene Interaction Panel Market: Hospitals (2020-2025) & ($ millions)
 Figure 14. Drug-Gene Interaction Panel in Cancer Research Institutes
 Figure 15. Global Drug-Gene Interaction Panel Market: Cancer Research Institutes (2020-2025) & ($ millions)
 Figure 16. Drug-Gene Interaction Panel in Reference Laboratories
 Figure 17. Global Drug-Gene Interaction Panel Market: Reference Laboratories (2020-2025) & ($ millions)
 Figure 18. Drug-Gene Interaction Panel in Others
 Figure 19. Global Drug-Gene Interaction Panel Market: Others (2020-2025) & ($ millions)
 Figure 20. Global Drug-Gene Interaction Panel Market Size Market Share by Application in 2024
 Figure 21. Global Drug-Gene Interaction Panel Revenue Market Share by Player in 2024
 Figure 22. Global Drug-Gene Interaction Panel Market Size Market Share by Region (2020-2025)
 Figure 23. Americas Drug-Gene Interaction Panel Market Size 2020-2025 ($ millions)
 Figure 24. APAC Drug-Gene Interaction Panel Market Size 2020-2025 ($ millions)
 Figure 25. Europe Drug-Gene Interaction Panel Market Size 2020-2025 ($ millions)
 Figure 26. Middle East & Africa Drug-Gene Interaction Panel Market Size 2020-2025 ($ millions)
 Figure 27. Americas Drug-Gene Interaction Panel Value Market Share by Country in 2024
 Figure 28. United States Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 29. Canada Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 30. Mexico Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 31. Brazil Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 32. APAC Drug-Gene Interaction Panel Market Size Market Share by Region in 2024
 Figure 33. APAC Drug-Gene Interaction Panel Market Size Market Share by Type (2020-2025)
 Figure 34. APAC Drug-Gene Interaction Panel Market Size Market Share by Application (2020-2025)
 Figure 35. China Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 36. Japan Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 37. South Korea Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 38. Southeast Asia Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 39. India Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 40. Australia Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 41. Europe Drug-Gene Interaction Panel Market Size Market Share by Country in 2024
 Figure 42. Europe Drug-Gene Interaction Panel Market Size Market Share by Type (2020-2025)
 Figure 43. Europe Drug-Gene Interaction Panel Market Size Market Share by Application (2020-2025)
 Figure 44. Germany Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 45. France Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 46. UK Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 47. Italy Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 48. Russia Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 49. Middle East & Africa Drug-Gene Interaction Panel Market Size Market Share by Region (2020-2025)
 Figure 50. Middle East & Africa Drug-Gene Interaction Panel Market Size Market Share by Type (2020-2025)
 Figure 51. Middle East & Africa Drug-Gene Interaction Panel Market Size Market Share by Application (2020-2025)
 Figure 52. Egypt Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 53. South Africa Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 54. Israel Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 55. Turkey Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 56. GCC Countries Drug-Gene Interaction Panel Market Size Growth 2020-2025 ($ millions)
 Figure 57. Americas Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 58. APAC Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 59. Europe Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 60. Middle East & Africa Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 61. United States Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 62. Canada Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 63. Mexico Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 64. Brazil Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 65. China Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 66. Japan Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 67. Korea Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 68. Southeast Asia Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 69. India Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 70. Australia Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 71. Germany Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 72. France Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 73. UK Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 74. Italy Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 75. Russia Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 76. Egypt Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 77. South Africa Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 78. Israel Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 79. Turkey Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)
 Figure 80. Global Drug-Gene Interaction Panel Market Size Market Share Forecast by Type (2026-2031)
 Figure 81. Global Drug-Gene Interaction Panel Market Size Market Share Forecast by Application (2026-2031)
 Figure 82. GCC Countries Drug-Gene Interaction Panel Market Size 2026-2031 ($ millions)

Companies Mentioned

Invitae Corporation

Neuberg Center for Genomic Medicine (NCGM)

Sonic Healthcare

10x Genomics

Integrated DNA Technologies

Celemics

Agena Bioscience

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff